| Liu X, Gomez-Pinillos A, Liu X, et al.
Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Puralpha-mediated decrease in androgen receptor levels. [JOURNAL ARTICLE]
Prostate 2009 Sep 29.
Abstract | Full Citation | Find Related Articles |
| Gravina GL, Biordi L, Martella F, et al.
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer. [Journal Article]
Int J Oncol 2009 Nov; 35(5):1133-9.
Abstract | Full Citation | Find Related Articles |
| Pal SK, Twardowski P, Josephson DY
Beyond castration and chemotherapy: Novel approaches to targeting androgen-driven pathways. [JOURNAL ARTICLE]
Maturitas 2009 Sep 4.
Abstract | Full Citation | Find Related Articles |
| Ham WS, Cho NH, Kim WT, et al.
Pathological effects of prostate cancer correlate with neuroendocrine differentiation and PTEN expression after bicalutamide monotherapy. [Journal Article, Research Support, Non-U.S. Gov't]
J Urol 2009 Oct; 182(4):1378-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Attar RM, Jure-Kunkel M, Balog A, et al.
Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancer. [Journal Article]
Cancer Res 2009 Aug 15; 69(16):6522-30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Desiniotis A, Schäfer G, Klocker H, et al.
Enhanced anti-proliferative and pro-apoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP dependent protein kinase A. [JOURNAL ARTICLE]
Int J Cancer 2009 Aug 3.
Abstract | Full Citation |
| Kimura T, Kiyota H, Nakata D, et al.
A novel androgen-dependent prostate cancer xenograft model derived from skin metastasis of a Japanese patient. [JOURNAL ARTICLE]
Prostate 2009 Jul 30.
Abstract | Full Citation |
| Neuwirt H, Puhr M, Cavarretta IT, et al.
[Androgens stimulate the expression of SOCS-3 and inhibits their effect on proliferation and secretion] [English Abstract, Journal Article]
Aktuelle Urol 2009 Aug; 40(4):231-4.
Abstract | Full Citation |
| Matousek RH, Sherwin BB
A randomized controlled trial of add-back estrogen or placebo on cognition in men with prostate cancer receiving an antiandrogen and a gonadotropin-releasing hormone analog. [JOURNAL ARTICLE]
Psychoneuroendocrinology 2009 Jul 15.
Abstract | Full Citation | Find Related Articles |
| Fuzio P, Lucarelli G, Perlino E, et al.
Androgen deprivation therapy regulation of beta1C integrin expression in prostate cancer. [Journal Article]
Oncol Rep 2009 Aug; 22(2):327-35.
Abstract | Full Citation | Find Related Articles |
   |
